Unsupervised Learning in Precision Medicine: Unlocking Personalized Healthcare through AI
Source abstract
Abstract
Integrating Artificial Intelligence (AI) into Precision Medicine (PM) is redefining healthcare, enabling personalized treatments tailored to individual patients based on their genetic code, environment, and lifestyle. AI’s ability to analyze vast and complex datasets, including genomics and medical records, facilitates the identification of hidden patterns and correlations, which are critical for developing personalized treatment plans. Unsupervised Learning (UL) is particularly valuable in PM as it can analyze unstructured and unlabeled data to uncover novel disease subtypes, biomarkers, and patient stratifications. By revealing patterns that are not explicitly labeled, unsupervised algorithms enable the discovery of new insights into disease mechanisms and patient variability, advancing our understanding of individual responses to treatment. However, the integration of AI into PM presents some challenges, including concerns about data privacy and the rigorous validation of AI models in clinical practice. Despite these challenges, AI holds immense potential to revolutionize PM, offering a more personalized, efficient, and effective approach to healthcare. Collaboration among AI developers and clinicians is essential to fully realize this potential and ensure ethical and reliable implementation in medical practice. This review will explore the latest emerging UL technologies in the biomedical field with a particular focus on PM applications and their impact on human health and well-being.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Machine Learning in Healthcare · Artificial Intelligence in Healthcare · COVID-19 diagnosis using AI
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy
Centro della Scienza e della Tecnica, Polo Universitario Grossetano, Via Ginori 41, 58100 Grosseto, Italy
Competence Center ARTES 4.0, 53100 Siena, Italy
References (81)
Show source-provided references
1. Precision Medicine, AI, and the Future of Personalized Health Care10.1111/cts.12884 ↗
2. Elsevier (2024). Attitudes to AI: A Global Survey of AI Use and Trust in Healthcare, Elsevier.
3. Babbage, C. (1824). On the Application of Machinery to the Computation of Astronomical and Mathematical Tables, Taylor.
4. Russell, S.J., and Norvig, P. (2021). Artificial Intelligence: A Modern Approach, Pearson. [4th ed.].
5. Bengio, Y., Courville, A., and Goodfellow, I. (2016). Deep Learning, MIT Press.
6. Machine Learning from Theory to Algorithms: An Overview10.1088/1742-6596/1142/1/012012 ↗
7. Bishop, C.M. (2006). Pattern Recognition and Machine Learning, Springer.
8. Hastie, T., Tibshirani, R., Friedman, J.H., and Friedman, J.H. (2009). The Elements of Statistical Learning: Data Mining, Inference, and Prediction, Springer. [2nd ed.].10.1007/978-0-387-84858-7 ↗
9. Cord, M., and Cunningham, P. (2008). Supervised Learning. Machine Learning Techniques for Multimedia, Springer.10.1007/978-3-540-75171-7 ↗
10. Unsupervised learning10.1016/j.ajodo.2023.04.001 ↗
11. Unsupervised machine learning methods and emerging applications in healthcare10.1007/s00167-022-07233-7 ↗
12. A review of clustering techniques and developments10.1016/j.neucom.2017.06.053 ↗
13. Deep learning-based clustering approaches for bioinformatics10.1093/bib/bbz170 ↗
14. Brain tumor segmentation using K-means clustering and deep learning with synthetic data augmentation for classification10.1002/jemt.23694 ↗
15. Feature dimensionality reduction: A review10.1007/s40747-021-00637-x ↗
16. Machine Learning for Anomaly Detection: A Systematic Review10.1109/ACCESS.2021.3083060 ↗
17. Kascenas, A., Pugeault, N., and O’Neil, A.Q. (2022, January 6–8). Denoising Autoencoders for Unsupervised Anomaly Detection in Brain MRI. Proceedings of the International Conference on Medical Imaging with Deep Learning, Zurich, Switzerland.
18. Explaining the Predictions of Unsupervised Learning Models
19. K-means-type algorithms: A generalized convergence theorem and characterization of local optimality10.1109/TPAMI.1984.4767478 ↗
20. Hierarchical clustering analysis framework of mutually exclusive crash causation parameters for regional road safety strategies10.1080/17457300.2017.1416485 ↗
21. K-means clustering algorithms: A comprehensive review, variants analysis, and advances in the era of big data10.1016/j.ins.2022.11.139 ↗
22. Principal component analysis: A review and recent developments10.1098/rsta.2015.0202 ↗
23. Visualizing data using t-SNE
24. Bank, D., Koenigstein, N., and Giryes, R. (2020). Autoencoders. arXiv.
25. One-class support vector classifiers: A survey10.1016/j.knosys.2020.105754 ↗
26. Improved autoencoder for unsupervised anomaly detection10.1002/int.22582 ↗
27. Muharremi, G., Meçani, R., and Muka, T. (2023). The Buzz Surrounding Precision Medicine: The Imperative of Incorporating It into Evidence-Based Medical Practice. J. Pers. Med., 14.10.3390/jpm14010053 ↗
28. Cecchin, E., and Stocco, G. (2020). Pharmacogenomics and Personalized Medicine. Genes, 11.10.3390/genes11060679 ↗
29. Visibelli, A., Cicaloni, V., Spiga, O., and Santucci, A. (2022). Computational Approaches Integrated in a Digital Ecosystem Platform for a Rare Disease. Front. Mol. Med., 2.10.3389/fmmed.2022.827340 ↗
30. Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalhães, P., Schmidt, S., and Vale, N. (2024). Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. Pharmaceutics, 16.10.3390/pharmaceutics16030332 ↗
31. Visibelli, A., Roncaglia, B., Spiga, O., and Santucci, A. (2023). The Impact of Artificial Intelligence in the Odyssey of Rare Diseases. Biomedicines, 11.10.3390/biomedicines11030887 ↗
32. Historical Root of Precision Medicine: An Ancient Concept Concordant with the Modern Pharmacotherapy10.1186/s40199-017-0173-1 ↗
33. European Commission (2014). Directorate-General for Health and Consumers, Unit D3 eHealth and Health Technology Assessment. The Use of Big Data in Public Health Policy and Research, European Commission.
34. Personalized Medicine-A Tradition in General Practice!10.1080/13814788.2019.1589806 ↗
35. Precision Medicine: Concept and Tools10.1016/j.mjafi.2021.06.021 ↗
36. What Is Precision Medicine?10.1183/13993003.00391-2017 ↗
37. Human Genomics Projects and Precision Medicine10.1038/gt.2017.77 ↗
38. New Clinical Trial Design in Precision Medicine: Discovery, Development and Direction10.1038/s41392-024-01760-0 ↗
39. Traditional Medicine: Past, Present and Future Research and Development Prospects and Integration in the National Health System of Cameroon10.4314/ajtcam.v8i3.65276 ↗
40. Li, X.L., Zhang, J.Q., Shen, X.J., Zhang, Y., and Guo, D.A. (2024). Overview and Limitations of Database in Global Traditional Medicines: A Narrative Review. Acta Pharmacol. Sin.10.1038/s41401-024-01353-1 ↗
41. Personalized Medicine Could Transform Healthcare10.3892/br.2017.922 ↗
42. A Precision Environmental Health Approach to Prevention of Human Disease10.1038/s41467-023-37626-2 ↗
43. Velmovitsky, P.E., Bevilacqua, T., Alencar, P., Cowan, D., and Morita, P.P. (2021). Convergence of Precision Medicine and Public Health into Precision Public Health: Toward a Big Data Perspective. Front. Public Health, 9.10.3389/fpubh.2021.561873 ↗
44. Precision Medicine Journey through Omics Approach10.1007/s40200-021-00913-0 ↗
45. Tebani, A., Afonso, C., Marret, S., and Bekri, S. (2016). Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations. Int. J. Mol. Sci., 17.10.3390/ijms17091555 ↗
46. Antonatos, C., Asmenoudi, P., Panoutsopoulou, M., and Vasilopoulos, Y. (2023). Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine. Int. J. Mol. Sci., 24.10.3390/ijms24087090 ↗
47. Liu, Y., Song, F., Li, Z., Chen, L., Xu, Y., Sun, H., and Chang, Y. (2023). A Comprehensive Tool for Tumor Precision Medicine with Pharmaco-Omics Data Analysis. Front. Pharmacol., 14.10.3389/fphar.2023.1085765 ↗
48. Molecular Dynamics: New Frontier in Personalized Medicine10.1016/bs.apcsb.2015.09.004 ↗
49. Functional, Electrophysiology, and Molecular Dynamics Analysis of Quercetin-Induced Contraction of Rat Vascular Musculature10.1016/j.ejphar.2022.174778 ↗
50. Hulsen, T., Jamuar, S.S., Moody, A.R., Karnes, J.H., Varga, O., Hedensted, S., Spreafico, R., Hafler, D.A., and McKinney, E.F. (2019). From Big Data to Precision Medicine. Front. Med., 6.10.3389/fmed.2019.00034 ↗
51. Prosperi, M., Min, J.S., Bian, J., and Modave, F. (2018). Big Data Hurdles in Precision Medicine and Precision Public Health. BMC Med. Inform. Decis. Mak., 18.10.1186/s12911-018-0719-2 ↗
52. Visibelli, A., Peruzzi, L., Poli, P., Scocca, A., Carnevale, S., Spiga, O., and Santucci, A. (2023). Supporting Machine Learning Model in the Treatment of Chronic Pain. Biomedicines, 11.10.3390/biomedicines11071776 ↗
53. Artificial Intelligence Approaches in Drug Discovery: Towards the Laboratory of the Future10.2174/1568026622666221006140825 ↗
54. Artificial Intelligence and Personalized Medicine10.1007/978-3-030-16391-4_11 ↗
55. Ethical Issues of Artificial Intelligence in Medicine and Healthcare
56. Data Privacy in Healthcare: In the Era of Artificial Intelligence10.4103/idoj.idoj_543_23 ↗
57. Communication-Efficient Learning of Deep Networks from Decentralized Data
58. Federated Machine Learning in Healthcare: A Systematic Review on Clinical Applications and Technical Architecture10.1016/j.xcrm.2024.101419 ↗
59. Addressing Bias in Big Data and AI for Health Care: A Call for Open Science10.1016/j.patter.2021.100347 ↗
60. Liu, M., Ning, Y., Ke, Y., Shang, Y., Chakraborty, B., Ong, M.E.H., Vaughan, R., and Liu, N. (2024). FAIM: Fairness-Aware Interpretable Modeling for Trustworthy Machine Learning in Healthcare. Patterns.10.1016/j.patter.2024.101059 ↗
61. Artificial Intelligence and Clinical Decision Support: Clinicians’ Perspectives on Trust, Trustworthiness, and Liability10.1093/medlaw/fwad013 ↗
62. Disease-Associated and Patient-Specific Immune Cell Signatures in Juvenile-Onset Systemic Lupus Erythematosus: Patient Stratification Using a Machine-Learning Approach10.1016/S2665-9913(20)30168-5 ↗
63. Nelke, C., Schroeter, C.B., Barman, S., Stascheit, F., Masanneck, L., Theissen, L., Huntemann, N., Walli, S., Cengiz, D., and Dobelmann, V. (2024). Identification of Disease Phenotypes in Acetylcholine Receptor-Antibody Myasthenia Gravis Using Proteomics-Based Consensus Clustering. eBioMedicine, 105.10.1016/j.ebiom.2024.105231 ↗
64. Precision Medicine in Diabetes: Application of K-Means Clustering to Optimize Treatment
65. Zhang, X., Li, Y., Wu, H., and Guo, S. (2024). Using K-Means Clustering to Identify Novel Phenotypes of Acute Ischemic Stroke. Front. Neurol., 15.10.3389/fneur.2024.1366307 ↗
66. Dutta, A., Pal, A., Bhadra, M., Khan, M.A., and Chakraborty, R. (2024). An Improved K-Means Algorithm for Effective Medical Image Segmentation. Math. Comput. Model., in press.
67. A Bayesian Machine Learning Approach for Drug Target Identification Using Diverse Data Types10.1038/s41467-019-12928-6 ↗
68. Drug Ranking Using Machine Learning Systematically Predicts the Efficacy of Anti-Cancer Drugs10.1038/s41467-021-22170-8 ↗
69. Unsupervised Ensemble-Based Phenotyping Enhances Discoverability of Genes Related to Left-Ventricular Morphology10.1038/s42256-024-00801-1 ↗
70. Constructing Personalized Characterizations of Structural Brain Aberrations in Patients with Dementia Using Explainable Artificial Intelligence10.1038/s41746-024-01123-7 ↗
71. Multiomic Neuropathology Improves Diagnostic Accuracy in Pediatric Neuro-Oncology10.1038/s41591-023-02255-1 ↗
72. Ex Vivo Drug Response Heterogeneity Reveals Personalized Therapeutic Strategies for Patients with Multiple Myeloma10.1038/s43018-023-00544-9 ↗
73. Multiplexed 3D Atlas of State Transitions and Immune Interaction in Colorectal Cancer10.1016/j.cell.2022.12.028 ↗
74. Mahdavi, M., Choubdar, H., Rostami, Z., Niroomand, B., Levine, A.T., Fatemi, A., Bolhasani, E., Vahabie, A.-H., Lomber, S.G., and Merrikhi, Y. (2023). Hybrid Feature Engineering of Medical Data via Variational Autoencoders with Triplet Loss: A COVID-19 Prognosis Study. Sci. Rep., 13.10.1038/s41598-023-29334-0 ↗
75. Yuan, B., Yang, D., Rothberg, B.E.G., Chang, H., and Xu, T. (2020). Unsupervised and Supervised Learning with Neural Network for Human Transcriptome Analysis and Cancer Diagnosis. Sci. Rep., 10.10.1038/s41598-020-75715-0 ↗
76. Molecular and Functional Landscape of Malignant Serous Effusions for Precision Oncology10.1038/s41467-024-52694-8 ↗
77. An End-to-End Deep Learning Method for Mass Spectrometry Data Analysis to Reveal Disease-Specific Metabolic Profiles10.1038/s41467-024-51433-3 ↗
78. A Context-Aware Deconfounding Autoencoder for Robust Prediction of Personalized Clinical Drug Response from Cell-Line Compound Screening10.1038/s42256-022-00541-0 ↗
79. Detecting Microstructural Deviations in Individuals with Deep Diffusion MRI Tractometry10.1038/s43588-021-00126-8 ↗
80. Kawi, O., Clawson, K., Dunn, P., Knight, D., Hodgson, J., and Peng, Y. (2020, January 19–24). Medical Formulation Recognition (MFR) Using Deep Feature Learning and One Class SVM. Proceedings of the 2020 International Joint Conference on Neural Networks (IJCNN), Glasgow, UK.10.1109/IJCNN48605.2020.9206955 ↗
81. Augmenting vascular disease diagnosis by vasculature-aware unsupervised learning10.1038/s42256-020-0188-z ↗